[Multiple myeloma. Biological, prognostic, and therapeutic aspects].
Corrado
C
C
Departamento de Oncohematología, Instituto de Investigaciones Hematológicas Mariano R. Castex, Buenos Aires, Argentina.
Pavlovsky
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000175:diagnosis / Q000235:genetics / Q000473:pathology / Q000628:therapy; D009194:Myeloma Proteins / Q000032:analysis; D010146:Pain / Q000532:radiotherapy; D010166:Palliative Care; D010954:Plasmacytoma / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis
D014408:Biomarkers, Tumor; D009194:Myeloma Proteins; D008558:Melphalan; D011241:Prednisone
Mieloma múltiple. Aspectos biológicos, pronósticos y terapéuticos.